Back to the main directory
EarningsReview / Equity
- Modulight - Still awaiting improvement in revenue trends by Danske Bank Equity Research
- JANA Partners Takes Activist Stake in Lamb Weston by BNP Paribas Exane
- Bangkok Bank (BBL TB) by HSBC
- Non material data changes by BNP Paribas Exane
- Building Momentum by BNP Paribas Exane
- H1 business update: unanswered questions by BNP Paribas Exane
- COFACE: coverage dropped by BNP Paribas Exane
- LANCASHIRE: coverage dropped by BNP Paribas Exane
- Competitor catch-up continues by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Q3’24 preview: first examination of defensive qualities by BNP Paribas Exane
- Exactly what we needed to see by BNP Paribas Exane
- Arctic Bioscience (No_rec, TP: NOK) - Recommendation and target price
withdrawn by DnB Markets
- Noble (Buy, TP: USD48.00) - Consolidation helped challenges by DnB Markets
- Norske Skog (Hold, TP: NOK32.00) - Decent earnings in tough markets by DnB Markets
- Weekly news, topics & discussion by DnB Markets
- Valuation and market update by DnB Markets
- Glass is (More Than) Half Full: Maintain Outperform Post In-Line 1Q and Reiterated FY25 Guidance by BNP Paribas Exane
- Autoliv (Buy, TP: SEK1270.00) - Relief rally by DnB Markets
- Avanza Bank (Buy, TP: SEK300.00) - Reassuring strategy update by DnB Markets
- Nokia (Hold, TP: EUR4.50) - Growth narrative starting to build by DnB Markets
- Getinge (Buy, TP: SEK245.00) - Soft earnings, but strong orders by DnB Markets
- Beat aside, margin stability is the key story by BNP Paribas Exane
- Weakening growth outlook more salient than the miss by BNP Paribas Exane
- Margin turnaround taking precedence by BNP Paribas Exane